P

Pliant Therapeutics
D

PLRX

3.08500
USD
0.08
(2.66%)
مغلق
حجم التداول
44,710
الربح لكل سهم
-4
العائد الربحي
-
P/E
-1
حجم السوق
187,733,427
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Pliant Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.